Mouse Blood Sampling

Selection starts with the study design and the amount of blood required. Tail-vein, saphenous-vein, and retro-orbital collection are listed options, but the overview does not assign one universally preferred method. Matching the collection approach to the required volume helps limit blood loss and supports analyses of hematological, biochemical, immunological, or pharmacological endpoints.

The intended measurement determines how the sample should be handled after collection. Whole blood can support hematological analysis, whereas processing into plasma or serum provides materials for measurements such as metabolites, antibodies, hormones, or drug concentrations. Keeping the sample form aligned with the assay helps researchers obtain information that matches the study question.

Restraint, aseptic technique, and post-collection hemostasis work together rather than serving as isolated steps. Appropriate restraint helps control the collection process, aseptic technique supports clean sampling, and hemostasis addresses bleeding afterward. Applying these measures while limiting blood loss can reduce animal stress and improve the consistency and ethical quality of biological research.

A basic workflow begins by defining the required volume and analysis, selecting a suitable collection route, and applying appropriate restraint. Blood is then collected with aseptic technique, followed by post-collection hemostasis. The specimen is processed as whole blood, plasma, or serum according to the intended measurement, creating a standardized path from mouse to analyzable sample.

For hematological studies, researchers may retain the specimen as whole blood so it can be used to examine cell populations. Immunological studies can use samples to measure antibodies, while biochemical studies can target metabolites or hormones after suitable sample processing. Thus, the same collection activity can support different biological questions when handling matches the endpoint.

In pharmacological research, collected blood can be used to measure drug concentrations. The study design must therefore account for the required volume and preserve a consistent collection and handling process across samples. Standardization makes concentration results easier to compare and supports reproducible interpretation of how a study compound is represented in the sampled blood.